DRDavid Q. Rich

David Q. Rich

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


David Q. Rich has a total of 257 co-authors. Here are the top co-authors by number of shared publications:

  • Philip K. Hopke

    University of Rochester School of Medicine and Dentistry

    17 shared publications
  • Junfeng Jim Zhang

    Nicholas School of the Environment, Duke University, Durham, North Carolina

    10 shared publications
  • Sally W. Thurston

    Department of Environmental Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA; Department of Biostatistics and Computational Biology, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA

    9 shared publications
  • David Chalupa

    Department of Environmental Medicine, University of Rochester Medical Center, Rochester, NY, USA

    7 shared publications
  • Philip K. Hopke

    Department of Public Health Sciences, University of Rochester Medical Center, Rochester, New York; Institute for a Sustainable Environment, Clarkson University, Potsdam, New York

    7 shared publications
  • Sally W. Thurston

    Department of Biostatistics and Computational Biology, University of Rochester

    7 shared publications

Latest Publications

  • Associations Between Short-Term Air Pollution and Immune Markers During Pregnancy in a Pittsburgh, Pennsylvania Pregnancy Cohort

    by C. S. Yount, K. Scheible, T. G. O’COnnor, T. A. Jusko, C. Buss, H. Simhan, P. Wadhwa, J. Tarr, S. W. Thurston, X. Qiu, et al.

  • Open Access

    The short-term association of PM2.5 and stroke: a time-stratified case-crossover study in Berlin, Germany

    by Jakob Beilstein, David Q. Rich, Heinrich J. Audebert, Toivo Glatz

    Exposure to fine particulate matter (PM 2.5 ) is a major, potentially preventable contributor to cardiovascular disease and death. PM 2.5 levels in many urban regions, including Berlin, exceed recommended thresholds. We assessed whether short-term PM 2.5 exposure is associated with ischemic stroke and transient ischemic attacks (TIA) in Berlin, Germany (2017–2020). We linked a population-based stroke registry with hourly PM 2.5 and meteorological measurements and applied a time-stratified case-crossover design with conditional logistic regression, adjusting for meteorological and time-varying factors (public holidays, pandemic period indicator). Associations were estimated at symptom onset and for the preceding 36 h using hourly lags. Among 9,565 ischemic stroke and TIA cases, a one-standard-deviation increase in PM 2.5 (10.28 µg/m 3 ) increased the odds of stroke occurrence by 2% (adjusted OR (aOR) 1.020, 95% CI [0.994, 1.047]). Lagged estimates showed a wave-like pattern with irregular peaks, whereby the second largest estimate occurred 18 h before symptom onset (aOR = 1.015, 95% CI [0.989, 1.042]). These findings are consistent with previously reported adverse short-term cerebrovascular effects of PM 2.5 . Although associations were modest and imprecise, PM 2.5 exposure is widespread and largely unavoidable in urban settings, so further reductions may yield population health benefits. This study investigated hourly lagged exposure, indicating that associations vary preceding symptom onset. Replication and pooled multi-city analyses with comparable high-resolution data are needed to more precisely identify critical exposure windows and to quantify benefits of further PM 2.5 reductions under tightened air quality guidelines.


  • PM2.5 and NO2 exposure during pregnancy and measures of fetal size and attained size at birth

    by Nafisa Nawal Islam, Sally W. Thurston, Donald Harrington, Yihui Ge, Samuel Weisenthal, Jessica Brunner, Richard K. Miller, Philip K. Hopke, Yan Lin, Emily S. Barrett, et al.

    Air pollution exposure during pregnancy has been associated with reduced fetal size and birth weight, but the sensitive exposure windows for these associations are not well established. We examined the association between gestational air pollution exposure and altered fetal size (femur length, biparietal diameter, head circumference, abdominal circumference, estimated fetal weight), measured in mid-pregnancy (week 20) and late-pregnancy (week 34), and attained size at birth (Z-scores of birth weight, length, and head circumference). Within the UPSIDE cohort study (N = 312 pregnant women) in Rochester, New York, we estimated residential, daily, ambient PM2.5 and NO2 concentrations using a spatial-temporal model. Distributed lag models estimated increases/decreases in each marker associated with interquartile range (IQR) increases in gestational week mean PM2.5 (3 µg/m3) and NO2 (9 ppb) concentrations, adjusting for child sex, maternal pre-pregnancy body mass index, race/ethnicity, and smoking during pregnancy. For birth measures, gestational age at birth was also included. Each IQR increase in NO2 in gestational weeks 18–33 was associated with decreased femur length at week 34 (-1.18 mm; 95% CI = -2.09, -0.27). However, each IQR increase during gestational weeks 8–9 was associated with increased femur length at week 20 (0.05 mm; 95% CI = 0.00, 0.09). No associations were observed between weekly NO2/PM2.5 concentrations and other fetal size or birth measures in models using all participants’ data. NO2/femur length associations differed by child sex. Thus, there was limited support for an association between gestational PM2.5/NO2 exposure and ultrasound measures of fetal size in mid- and late- pregnancy.


  • Prenatal air pollution exposure and placental vasculature development among participants of the UPSIDE cohort study

    by Shivram Kumar, Carolyn M. Salafia, Ruchit Shah, Theresa Girardi, Richard K. Miller, Sally W. Thurston, Philip K. Hopke, David Skrill, Jessica Brunner, Donald Harrington, et al.


  • Open Access

    Gestational exposure to PM2.5, NO2, and sex steroid hormones: Identifying critical windows of exposure in the Rochester UPSIDE Cohort

    by Mariah Kahwaji, Luke Duttweiler, Sally W. Thurston, Donald Harrington, Richard K. Miller, Susan K. Murphy, Christina Wang, Jessica Brunner, Yihui Ge, Yan Lin, et al.

    Background: Sex steroid hormones are critical for maintaining pregnancy and optimal fetal development. Air pollutants are potential endocrine disruptors that may disturb sex steroidogenesis during pregnancy, potentially leading to adverse health outcomes. Methods: In the Environmental influences on Child Health Outcomes Understanding Pregnancy Signals and Infant Development pregnancy cohort (Rochester, NY), sex steroid concentrations were collected at study visits in early-, mid-, and late-pregnancy in 299 participants. Since these visits varied by the gestational age at blood draw, values were imputed at 14, 22, and 30 weeks gestation. Daily NO2 and PM2.5 concentrations were estimated using random forest models, with daily concentrations from each 1-km2 grid containing the subject’s residence. Associations between gestational week mean NO2 and PM2.5 concentrations and sex steroid concentrations were examined utilizing distributed lag nonlinear models. Results: Each interquartile range (IQR = 9 ppb) increase in NO2 during weeks 0–5 was associated with higher early-pregnancy total testosterone levels (cumulative β = 0.45 ln[ng/dl]; 95% CI = 0.07, 0.83), while each IQR increase in NO2 during weeks 12–14 was associated with lower early-pregnancy total testosterone levels (cumulative β = −0.27 ln[ng/dl]; 95% CI = −0.53, −0.01). Similar NO2 increases during gestational weeks 0–14 were associated with higher late-pregnancy estradiol concentrations (cumulative β = 0.29 ln[pg/ml]; 95% CI = 0.10, 0.49), while each IQR increase in NO2 concentrations during gestational weeks 22–30 was associated with lower late-pregnancy estradiol concentrations (cumulative β = −0.18 ln[pg/ml]; 95% CI = −0.34, −0.02). No associations with PM2.5 were observed, except for an IQR increase in PM2.5 concentrations (IQR = 4 µg/m3) during gestational weeks 5–11 which was associated with lower late-pregnancy estriol levels (cumulative β = −0.16 ln[ng/ml]; 95% CI = −0.31, −0.00). Conclusions: Residential NO2 exposure was associated with altered sex steroid hormone concentrations during pregnancy with some indication of potential compensatory mechanisms.


  • Open Access

    Historical Research on Aerosol Number Concentrations, Classifications of Air Pollution Severity and Particle Retention: Lessons for Present-Day Researchers

    by Patrick Goodman, Eoin J. McGillicuddy, R. Giles Harrison, David Q. Rich, John A. Scott

    Research into the adverse health effects of air pollution exposure has repeatedly considered smaller particles, to the point where particle number concentration might be a more relevant metric than mass concentration. Here, we highlight some historical research which developed metrics for air pollution severity based on particle number concentration. Because this work was published in a national journal and prior to the internet and open access, this historical research is not easy to find, and it was more through the history of the aerosol research community in Ireland that this work is now being presented. Multiple online searches for published research papers on “particle number concentrations” and “air pollution severity” were undertaken. Even when specific searches were undertaken using the author names and publication year, these featured papers were not found on any internet search. O’Dea and O’Connor proposed that air pollution severity could be classified based on particle number concentration of condensation nuclei, with ‘little’ air pollution 100 × 103 particles per cm3. Applying their assumptions on density and mean particle size, equated to mass concentrations for a mean of 6 µgm−3, strong at 8.5 µgm−3, and very strong >10 µgm−3. These are consistent with the current WHO guideline values for PM2.5. Additionally, we highlight the 1955 work by Burke and Nolan on the retention of inhaled particles, where ~40% of the inhaled number concentration is retained in the respiratory system. This is also consistent with the more recently published work on particle retention. In summary, the proposed categories of pollution severity, based on number concentrations, could form a basis for the development of future guidelines. This paper highlights that sometimes research has already been published, but it is difficult to find. We challenge researchers to find publications from their own countries which pre-date the WWW to inform current and future research. Additionally, there is scope for a repository for such information on historical publications. We have presented historical research on aerosol number concentrations, classifications of air pollution severity, and particle retention, which present lessons for current researchers.


  • Open Access

    Source specific fine particles and rates of asthma and COPD healthcare encounters pre- and post-implementation of the Tier 3 vehicle emissions control regulations

    by Shao Lin, Yukang Xue, Sathvik Thandra, Quan Qi, Sally W. Thurston, Daniel P. Croft, Mark J. Utell, Philip K. Hopke, David Q. Rich


  • Open Access

    A case-crossover study of ST-elevation myocardial infarction and organic carbon and source-specific PM2.5 concentrations in Monroe County, New York

    by Tianming Zhao, Philip K. Hopke, Mark J. Utell, Daniel P. Croft, Sally W. Thurston, Shao Lin, Frederick S. Ling, Yunle Chen, Catherine S. Yount, David Q. Rich

    Background: Previous work reported increased rates of cardiovascular hospitalizations associated with increased source-specific PM2.5 concentrations in New York State, despite decreased PM2.5 concentrations. We also found increased rates of ST elevation myocardial infarction (STEMI) associated with short-term increases in concentrations of ultrafine particles and other traffic-related pollutants in the 2014–2016 period, but not during 2017–2019 in Rochester. Changes in PM2.5 composition and sources resulting from air quality policies (e.g., Tier 3 light-duty vehicles) may explain the differences. Thus, this study aimed to estimate whether rates of STEMI were associated with organic carbon and source-specific PM2.5 concentrations.Methods: Using STEMI patients treated at the University of Rochester Medical Center, compositional and source-apportioned PM2.5 concentrations measured in Rochester, a time-stratified case-crossover design, and conditional logistic regression models, we estimated the rate of STEMI associated with increases in mean primary organic carbon (POC), secondary organic carbon (SOC), and source-specific PM2.5 concentrations on lag days 0, 0–3, and 0–6 during 2014–2019.Results: The associations of an increased rate of STEMI with interquartile range (IQR) increases in spark-ignition emissions (GAS) and diesel (DIE) concentrations in the previous few days were not found from 2014 to 2019. However, IQR increases in GAS concentrations were associated with an increased rate of STEMI on the same day in the 2014–2016 period (Rate ratio [RR] = 1.69; 95% CI = 0.98, 2.94; 1.73 μg/m3). In addition, each IQR increase in mean SOC concentration in the previous 6 days was associated with an increased rate of STEMI, despite imprecision (RR = 1.14; 95% CI = 0.89, 1.45; 0.42 μg/m3).Conclusion: Increased SOC concentrations may be associated with increased rates of STEMI, while there seems to be a declining trend in adverse effects of GAS on triggering of STEMI. These changes could be attributed to changes in PM2.5 composition and sources following the Tier 3 vehicle introduction.


  • Open Access

    PM2.5 and its components and respiratory disease healthcare encounters – Unanticipated increased exposure-response relationships in recent years after environmental policies

    by Shao Lin, Yukang Xue, Sathvik Thandra, Quan Qi, Philip K. Hopke, Sally W. Thurston, Daniel P. Croft, Mark J. Utell, David Q. Rich


  • Short term air pollution exposure during pregnancy and associations with maternal immune markers

    by C.S. Yount, K. Scheible, S.W. Thurston, X. Qiu, Y. Ge, P.K. Hopke, Y. Lin, R.K. Miller, S.K. Murphy, J. Brunner, et al.